Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Inhibition of Pro-inflammatory and Anti-apoptotic Biomarkers during Experimental Oral Cancer Chemoprevention by Dietary Black Raspberries.

Oghumu S, Casto BC, Ahn-Jarvis J, Weghorst LC, Maloney J, Geuy P, Horvath KZ, Bollinger CE, Warner BM, Summersgill KF, Weghorst CM, Knobloch TJ.

Front Immunol. 2017 Oct 23;8:1325. doi: 10.3389/fimmu.2017.01325. eCollection 2017.

2.

Suppression of Proinflammatory and Prosurvival Biomarkers in Oral Cancer Patients Consuming a Black Raspberry Phytochemical-Rich Troche.

Knobloch TJ, Uhrig LK, Pearl DK, Casto BC, Warner BM, Clinton SK, Sardo-Molmenti CL, Ferguson JM, Daly BT, Riedl K, Schwartz SJ, Vodovotz Y, Buchta AJ Sr, Schuller DE, Ozer E, Agrawal A, Weghorst CM.

Cancer Prev Res (Phila). 2016 Feb;9(2):159-71. doi: 10.1158/1940-6207.CAPR-15-0187. Epub 2015 Dec 23.

3.

Chemoprevention of oral cancer by topical application of black raspberries on high at-risk mucosa.

Warner BM, Casto BC, Knobloch TJ, Accurso BT, Weghorst CM.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2014 Dec;118(6):674-83. doi: 10.1016/j.oooo.2014.09.005. Epub 2014 Sep 16.

4.

Cyclooxygenase-2 and the inflammogenesis of breast cancer.

Harris RE, Casto BC, Harris ZM.

World J Clin Oncol. 2014 Oct 10;5(4):677-92. doi: 10.5306/wjco.v5.i4.677. Review.

5.

Chemoprevention of oral cancer by lyophilized strawberries.

Casto BC, Knobloch TJ, Galioto RL, Yu Z, Accurso BT, Warner BM.

Anticancer Res. 2013 Nov;33(11):4757-66.

6.

Chemoprevention of mouse lung and colon tumors by suberoylanilide hydroxamic acid and atorvastatin.

Pereira MA, Warner BM, Knobloch TJ, Weghorst CM, Lubet RA, Steele VE, Casto BC.

Int J Cancer. 2012 Sep 15;131(6):1277-86. doi: 10.1002/ijc.27395. Epub 2012 Jan 31.

7.
8.

Oral cancer in Appalachia.

Casto BC, Sharma S, Fisher JL, Knobloch TJ, Agrawal A, Weghorst CM.

J Health Care Poor Underserved. 2009 Feb;20(1):274-85. doi: 10.1353/hpu.0.0097.

PMID:
19202262
9.

Frequent alterations of p16INK4a and p14ARF in oral proliferative verrucous leukoplakia.

Kresty LA, Mallery SR, Knobloch TJ, Li J, Lloyd M, Casto BC, Weghorst CM.

Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):3179-87. doi: 10.1158/1055-9965.EPI-08-0574.

10.

Laboratory and clinical studies of cancer chemoprevention by antioxidants in berries.

Stoner GD, Wang LS, Casto BC.

Carcinogenesis. 2008 Sep;29(9):1665-74. doi: 10.1093/carcin/bgn142. Epub 2008 Jun 9. Review.

11.

Tumor suppressor p16(INK4A)/Cdkn2a alterations in 7, 12-dimethylbenz(a)anthracene (DMBA)-induced hamster cheek pouch tumors.

Li J, Warner B, Casto BC, Knobloch TJ, Weghorst CM.

Mol Carcinog. 2008 Oct;47(10):733-8. doi: 10.1002/mc.20424.

12.

Frequent p16INK4A/CDKN2A alterations in chemically induced Syrian golden hamster pancreatic tumors.

Li J, Weghorst CM, Tsutsumi M, Poi MJ, Knobloch TJ, Casto BC, Melvin WS, Tsai MD, Muscarella P.

Carcinogenesis. 2004 Feb;25(2):263-8. Epub 2003 Nov 6.

PMID:
14604895
13.

Chemoprevention of oral cancer by black raspberries.

Casto BC, Kresty LA, Kraly CL, Pearl DK, Knobloch TJ, Schut HA, Stoner GD, Mallery SR, Weghorst CM.

Anticancer Res. 2002 Nov-Dec;22(6C):4005-15.

PMID:
12553025
14.

Alterations of p16(INK4a) and p14(ARF) in patients with severe oral epithelial dysplasia.

Kresty LA, Mallery SR, Knobloch TJ, Song H, Lloyd M, Casto BC, Weghorst CM.

Cancer Res. 2002 Sep 15;62(18):5295-300.

15.

Identification and sequencing of the Syrian Golden hamster (Mesocricetus auratus) p16(INK4a) and p15(INK4b) cDNAs and their homozygous gene deletion in cheek pouch and pancreatic tumor cells.

Muscarella P, Knobloch TJ, Ulrich AB, Casto BC, Moniaux N, Wittel UA, Melvin WS, Pour PM, Song H, Gold B, Batra SK, Weghorst CM.

Gene. 2001 Oct 31;278(1-2):235-43.

PMID:
11707341
16.

Effects of 10-hydroxycamptothecin, delivered from locally injectable poly(lactide-co-glycolide) microspheres, in a murine human oral squamous cell carcinoma regression model.

Mallery SR, Shenderova A, Pei P, Begum S, Ciminieri JR, Wilson RF, Casto BC, Schuller DE, Morse MA.

Anticancer Res. 2001 May-Jun;21(3B):1713-22.

PMID:
11497251
17.

Analysis of TGF-beta type I receptor for mutations and polymorphisms in head and neck cancers.

Knobloch TJ, Lynch MA, Song H, DeGroff VL, Casto BC, Adams EM, Alam KY, Lang JC, Schuller DE, Weghorst CM.

Mutat Res. 2001 Aug 8;479(1-2):131-9.

PMID:
11470488
18.

Responsiveness to transforming growth factor-beta (TGF-beta)-mediated growth inhibition is a function of membrane-bound TGF-beta type II receptor in human breast cancer cells.

Lynch MA, Petrel TA, Song H, Knobloch TJ, Casto BC, Ramljak D, Anderson LM, DeGroff V, Stoner GD, Brueggemeier RW, Weghorst CM.

Gene Expr. 2001;9(4-5):157-71.

19.

Somatic INK4a-ARF locus mutations: a significant mechanism of gene inactivation in squamous cell carcinomas of the head and neck.

Poi MJ, Yen T, Li J, Song H, Lang JC, Schuller DE, Pearl DK, Casto BC, Tsai MD, Weghorst CM.

Mol Carcinog. 2001 Jan;30(1):26-36.

PMID:
11255261
20.

Genetic alterations in the transforming growth factor receptor complex in sporadic endometrial carcinoma.

Nakashima R, Song H, Enomoto T, Murata Y, McClaid MR, Casto BC, Weghorst CM.

Gene Expr. 1999;8(5-6):341-52.

21.
22.

Malignant conversion of human cells by antisense cDNA to a putative tumor suppressor gene.

Li D, Yan H, Chen J, Casto BC, Theil KS, Milo GE.

Carcinogenesis. 1996 Aug;17(8):1751-5.

PMID:
8761437
23.

Malignant conversion of chemically transformed normal human cells.

Milo GE, Li D, Casto BC, Theil K, Shuler C, Noyes I, Chen J.

Proc Natl Acad Sci U S A. 1996 May 28;93(11):5229-34.

24.

A conundrum in molecular toxicology: molecular and biological changes during neoplastic transformation of human cells.

Milo GE, Shuler CF, Lee H, Casto BC.

Cell Biol Toxicol. 1995 Dec;11(6):329-45. Review.

PMID:
8788209
25.

Results of toxicological testing of Jefferson Parish pilot plant samples.

Miller RG, Kopfler FC, Condie LW, Pereira MA, Meier JR, Ringhand HP, Robinson M, Casto BC.

Environ Health Perspect. 1986 Nov;69:129-39.

26.

Conditions for transformation of human fibroblast cells: an overview.

Milo GE, Casto BC.

Cancer Lett. 1986 Apr;31(1):1-13. Review.

PMID:
3516378
27.
28.

Cell transformation by chemical agents--a review and analysis of the literature. A report of the U.S. Environmental Protection Agency Gene-Tox Program.

Heidelberger C, Freeman AE, Pienta RJ, Sivak A, Bertram JS, Casto BC, Dunkel VC, Francis MW, Kakunaga T, Little JB, Schechtman LM.

Mutat Res. 1983 Apr;114(3):283-385. Review.

PMID:
6339891
29.

Synergism in the transformation of hamster embryo cells treated with formaldehyde and adenovirus.

Hatch GG, Conklin PM, Christensen CC, Casto BC, Nesnow S.

Environ Mutagen. 1983;5(1):49-57.

PMID:
6832085
31.
32.

Increased integration of viral genome following chemical and viral treatment of hamster embryo cells.

Casto BC, Miyagi M, Meyers J, Di Paolo JA.

Chem Biol Interact. 1979 May;25(2-3):255-69.

PMID:
111805
33.
34.

Quantitative studies of in vitro morphological transformation of Syrian hamster cells by inorganic metal salts.

DiPaolo JA, Casto BC.

Cancer Res. 1979 Mar;39(3):1008-13. No abstract available.

35.
36.
37.

In vitro carcinogenesis with cells in early passage.

DiPaolo JA, Casto BC.

Natl Cancer Inst Monogr. 1978 May;(48):245-57. Review.

PMID:
372816
38.

Characteristics of hamster cells transformed by the combined action of chemical and virus.

Hatch GG, Balwierz PJ, Casto BC, DiPaolo JA.

Int J Cancer. 1978 Jan 15;21(1):121-7.

PMID:
624597
39.

Development of a focus assay model for transformation of hamster cells in vitro by chemical carcinogens.

Casto BC, Janosko N, DiPaolo JA.

Cancer Res. 1977 Oct;37(10):3508-15. No abstract available.

40.

Significance of treatment interval and DNA repair in the enhancement of viral transformation by chemical carcinogens and mutagens.

Casto BC, Pieczynski WJ, Janosko N, Dipaolo JA.

Chem Biol Interact. 1976 May;13(2):105-25.

PMID:
816474
41.

Infrequent chromosome aberrations in Syrian hamster cells following partial synchrony by amino-acid deprivation.

Popescu NC, Casto BC, DiPaolo JA.

J Cell Physiol. 1975 Dec;86 Suppl 2(3 Pt 2):599-604.

PMID:
1202036
42.

RNA type C virus antigens in hamster cells transformed by carcinogenic DNA viruses and chemicals.

Hatch GG, Casto BC, McCormick KJ, Trentin JJ.

Cancer Res. 1975 Dec;35(12):3792-7.

43.

In vitro transformation: interaction of chemicals, viruses, and irradiation.

Casto BC, diPaolo JA.

Bibl Haematol. 1975;(40):197-9. No abstract available.

PMID:
169809
44.

Enhancement by alkylating agents of chemical carcinogen transformation of hamster cells in culture.

DiPaolo JA, Donovan PJ, Casto BC.

Chem Biol Interact. 1974 Nov;9(5):351-64. No abstract available.

PMID:
4373182
45.

Random chromosome changes following SA7 transformation of Syrian hamster cells.

Popescu NC, Olinici CD, Casto BC, DiPaolo JA.

Int J Cancer. 1974 Oct 15;14(4):461-72. No abstract available.

PMID:
4218597
46.

Enhancement of adenovirus transformation by treatment of hamster embryo cells with diverse chemical carcinogens.

Casto BC, Pieczynski WJ, DiPaolo JA.

Cancer Res. 1974 Jan;34(1):72-8. No abstract available.

47.

Enhancement of adenovirus transformation by pretreatment of hamster cells with carcinogenic polycyclic hydrocarbons.

Casto BC, Pieczynski WJ, DiPaolo JA.

Cancer Res. 1973 Apr;33(4):819-24. No abstract available.

49.

Virus, chemicals and cancer.

Casto BC, DiPaolo JA.

Prog Med Virol. 1973;16:1-47. Review. No abstract available.

PMID:
4591689
50.

Inhibition of adenovirus transformation in vitro by AAV-1.

Casto BC, Goodheart CR.

Proc Soc Exp Biol Med. 1972 May;140(1):72-8. No abstract available.

PMID:
5033120

Supplemental Content

Loading ...
Support Center